BSX
BOSTON SCIENTIFIC CORP
NYSE: BSX · Marlborough, MA · Healthcare
$48.96+0.26 (+0.53%)Closed
Market Cap$68.49B
Cash$1.45Bmost recent
Runwayprofitable
P/E (TTM)25.2EPS $1.94
52-Wk Range$47.68 – $108.14
Avg Volume12.5M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$48.96-36.8%
Pipeline

Drug candidates sponsored by BOSTON SCIENTIFIC · ClinicalTrials.gov

100 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 4Unnamed
Coronary Artery Disease
Completed
2007-04past
1
Phase 4Unnamed
Heart Failure
Completed
2009-01past
1
Phase 4Unnamed
Heart Failure, Congestive
Completed
2012-11past
1
Phase 4Unnamed
Failed Back Surgery Syndrome+2 more
Terminated
2013-05past
1
Phase 4Alteplase
Deep Vein Thrombosis+1 more
Completed
2017-11-30past
1
Phase 4Unnamed
Bradycardia
Completed—1
Phase 3Unnamed
Coronary Artery Disease
Completed
2006-12past
1
Phase 3Unnamed
Coronary Artery Disease
Completed
2007-02past
1
Phase 3Unnamed
Overactive Bladder
Completed
2008-03past
1
Phase 3Unnamed
Urinary Incontinence
Completed
2008-07past
1
Phase 3endovenous ablation+polidocanol injectable microfoam 0.125%
Great Saphenous Vein Incompetence+1 more
Completed
2012-03past
1
Phase 2Unnamed
Emphysema
Completed
2013-03past
1
Phase 3Sorafenib
Hepatocellular Carcinoma+2 more
Terminated
2017-06-05past
1
Phase 2Unnamed
Heart Failure
Completed—1
Phase 2Unnamed
Congestive Heart Failure
Completed—1
Phase 2Unnamed
Congestive Heart Failure
Completed—1
Phase 1Unnamed
Chronic Headaches
Completed
2007-08past
1
Phase 2Unnamed
Migraine
Terminated
2008-11past
1
Phase 1OncoGel (ReGel/Paclitaxel)
Glioblastoma Multiforme+1 more
Terminated
2009-10past
1
Phase 2Polidocanol Endovenous Microfoam 0.125%
Varicose Veins
Completed
2009-12past
1
Phase 2Unnamed
Colorectal Cancer+2 more
Completed
2011-03past
1
Phase 2Pleneva TM BGC20-0134
Relapsing Remitting Multiple Sclerosis
Terminated
2011-12past
1
Phase 1Unnamed
Pain+1 more
Withdrawn
2014-03past
1
N/AControl
Asthma
Completed
2006-02past
1
N/AUnnamed
Arrhythmia
Completed
2008-10past
1
N/AUnnamed
Stress Urinary Incontinence
Completed
2008-11past
1
N/AUnnamed
ACC/AHA/NASPE Class 1, IIa or IIb Indications
Completed
2009-03past
1
N/AUnnamed
Heart Failure
Completed
2009-05past
1
N/AUnnamed
Asthma
Completed
2009-12past
1
N/AUnnamed
Coronary Artery Disease
Completed
2011-08past
1
N/AUnnamed
Sinus Node Disease+2 more
Completed
2012-06past
1
N/AUnnamed
Heart Failure
Completed
2012-06past
1
N/AUnnamed
Coronary Heart Disease
Completed
2012-06past
1
N/AUnnamed
Primary Prevention of Sudden Cardiac Arrest
Completed
2012-08past
1
N/AUnnamed
Heart Failure+1 more
Completed
2012-09past
1
N/AUnnamed
Prostatic Hyperplasia+7 more
Completed
2013-02past
1
N/AUnnamed
Ventricular Fibrillation+1 more
Completed
2013-10past
1
N/AUnnamed
Hypertension
Completed
2013-11past
1
N/AUnnamed
Aortic Stenosis
Completed
2013-12-10past
1
N/AUnnamed
Heart Failure+1 more
Active, not recruiting
2014-05past
1
N/AUnnamed
Tachycardia
Completed
2014-06past
1
N/AUnnamed
Atherosclerosis of Native Arteries of the Extremities
Completed
2014-12past
1
N/AUnnamed
Chronic Pain
Completed
2015-02past
1
N/AUnnamed
Refractory Pancreatic Duct Strictures+1 more
Completed
2015-06past
1
N/AUnnamed
Cardiovascular Diseases
Completed
2015-10past
1
N/AUnnamed
Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke
Completed
2015-11past
1
N/AUnnamed
Bradyarrhythmia
Completed
2016-11past
1
N/AUnnamed
Lumbar Spinal Stenosis+1 more
Completed
2017-02past
1
N/AUnnamed
Post Market Surveillance Study Following Clinical Routine
Completed
2017-03past
1
N/AUnnamed
Magnetic Resonance Imaging
Completed
2017-04-30past
1
N/AUnnamed
Benign Prostatic Hyperplasia+6 more
Completed
2017-05-19past
1
N/AUnnamed
Emphysema
Terminated
2017-06past
1
N/AUnnamed
Peripheral Arterial Disease
Completed
2017-06-29past
1
N/AUnnamed
Hypertension
Completed
2017-09-07past
1
N/AUnnamed
Atrial Fibrillation Non-Rheumatic
Completed
2018-02-01past
1
N/AUnnamed
Urinary Tract Disease
Completed
2019-05-09past
1
N/AUnnamed
Arrhythmias, Cardiac
Completed
2019-05-23past
1
N/AUnnamed
Asthma
Completed
2019-06-26past
1
N/AUnnamed
Peripheral Arterial Disease
Completed
2019-11-08past
1
N/AUnnamed
Fallopian Tube Cancer+10 more
Completed
2020-02-14past
1
N/AVarithena
Venous Leg Ulcer
Completed
2020-05-18past
1
N/AUnnamed
Heart Failure
Completed
2020-09-15past
1
N/AUnnamed
Hepatocellular Carcinoma (HCC)
Withdrawn
2020-10-30past
1
N/AUnnamed
Pancreatic Pseudocyst Infection+3 more
Completed
2020-10-30past
1
N/AUnnamed
Hepatocellular Carcinoma
Completed
2020-12-01past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2020-12-07past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2020-12-21past
1
N/AUnnamed
Coronary Artery Disease
Completed
2020-12-28past
1
N/AUnnamed
Pancreatic Cancer
Completed
2021-05-01past
1
N/AUnnamed
Pancreatic Carcinoma
Completed
2021-12-13past
1
N/AUnnamed
Aortic Valve Stenosis+2 more
Active, not recruiting
2022-03-09past
1
N/AUnnamed
Intraductal Papillary Mucinous Neoplasm
Active, not recruiting
2022-08-11past
1
N/AUnnamed
Atherosclerosis+3 more
Completed
2022-08-19past
1
N/AUnnamed
Atrial Tachycardia (Including Atrial Flutter) Post Atrial Fibrillation Ablation or Cardiac Surgery
Withdrawn
2022-12past
1
N/AUnnamed
Ureter Obstruction
Completed
2023-01-16past
1
N/AUnnamed
Lumbar Spinal Stenosis
Completed
2023-03-20past
1
N/AUnnamed
Persistent Atrial Fibrillation
Withdrawn
2023-04-30past
1
N/AUnnamed
Orthostatic Hypotension+1 more
Completed
2023-05-08past
1
N/AUnnamed
Biliary Stones
Completed
2023-09-18past
1
N/AUnnamed
Chronic Low Back Pain
Completed
2024-02-01past
1
N/AUnnamed
Pain, Chronic
Completed
2024-03-08past
1
N/AUnnamed
Paroxysmal Atrial Fibrillation
Completed
2024-05-03past
1
N/AUnnamed
Stress Urinary Incontinence
Completed
2024-05-13past
1
N/AUnnamed
Atrial Fibrillation+2 more
Completed
2024-07-15past
1
N/AUnnamed
High-risk Percutaneous Coronary Intervention+1 more
Completed
2024-10-24past
1
N/AUnnamed
Atrial Fibrillation
Active, not recruiting
2025-10-21past
1
N/AUnnamed
Obesity
Recruiting
2026-06past
1
N/AUnnamed
Atrial Fibrillation+2 more
Active, not recruiting
2026-07
1
N/AUnnamed
Respiration Rate Detection
Not yet recruiting
2026-07
1
N/AUnnamed
Atrial Arrhythmia+1 more
Not yet recruiting
2026-12-31
1
N/AUnnamed
Persistent Atrial Fibrillation
Recruiting
2027-04
1
N/AUnnamed
Non-valvular Atrial Fibrillation (AF)+1 more
Recruiting
2027-08
1
N/AUnnamed
Prostate+1 more
Active, not recruiting
2028-01
1
N/AUnnamed
Obesity
Recruiting
2028-04-07
1
N/AUnnamed
Anastomotic Leaks+1 more
Recruiting
2028-12
1
N/AUnnamed
Parkinson Disease+2 more
Recruiting
2028-12
1
N/AUnnamed
Erectile Dysfunction
Enrolling
2031-01
1
N/AUnnamed
Coronary Artery Disease
Completed—1
N/AUnnamed
Complex Regional Pain Syndrome+2 more
Withdrawn—1
N/AUnnamed
Asthma
Withdrawn—1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for BSX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.